Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Audited Financial Results Of The Company For The Fourth Quarter And Financial Year Ended 31St March, 2021

 Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 28th June, 2021 has inter-alia, considered, adopted and approved Audited Financial Results of the Company for the fourth quarter and financial year ended 31st March, 2021. A copy of Audited Financial Results along with Auditors Report thereon is enclosed herewith.
28-06-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Please find enclosed herewith the Annual Secretarial Compliance Report of the Company for the financial year ended 31st March, 2021 pursuant to SEBI Circular CIR/CFD/CMD1/27/2019 dated 8th February, 2019.
24-06-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Corporate Action-Board to consider Dividend

 Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Monday, June 28, 2021 at 3:00 P.M. at the Registered Office of the Company
19-06-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for The Approval Of The Audited Financial Statements For Quarter And Financial Year Ended 31St March, 2021 Along With Audit Report Of The Auditor Thereon And To Recommend Final Dividend For FY 2020-2021, If Any

 Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Monday, June 28, 2021 at 3:00 P.M. at the Registered Office of the Company
19-06-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Meeting Updates

 In compliance to Regulation 30 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Friday, June 11, 2021; at 10.30 a.m. had considered and approved various business opportunities of the Company and discussed the other General Matters related to the Company.
11-06-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Half Yearly Certificate Under Regulation 40 (9) & 40 (10) Of SEBI Listing Regulations, 2015

 In compliance to Regulation 40 (9) & 40 (10) of SEBI (Listing Regulations), 2015; we furnish hereunder the Certificate for the half year ended March 31, 2021 of Fredun Pharmaceuticals Limited as issued by Rajendra & Co., Practising Company Secretaries.
16-04-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Shareholding for the Period Ended March 31, 2021

 Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
09-04-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliance Certificate For The Half Year Ended 31St March, 2021

 In Compliance to Regulation 7(3) of SEBI Listing Regulations, 2015; we furnish hereunder the Certificate, duly signed by the Company Secretary of Fredun Pharmaceuticals Limited and by the Compliance Officer of 'Purva Sharegistry (India) Private Ltd.' , designated Share Transfer Agent of the Company for the half year ended March 31, 2021.
02-04-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Format Of Initial Disclosure To Be Made By An Entity Identified As A Large Corporate

 We would like to inform that the Company is not a large Corporate as per the criteria provided in clause 2.2 of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018 and BSE Circular dated 11th April, 2019 for the year ended March 31, 2021. Accordingly, the initial disclosure in Annexure A to the said circular is not applicable to the Company.
02-04-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In Compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder the confirmation certificate received from the SEBI Registered Share Transfer Agent viz. Purva Sharegistry (India) Pvt. Ltd of the Company for the Quarter ended 31st March, 2021.
02-04-2021
Next Page
Close

Let's Open Free Demat Account